New Funding Awards - February 2022

Thursday, March 17, 2022

Sponsored Research

Koki Abe (Mentor: Tomokazu Souma) of Nephrology has received an award from the The Uehara Memorial Foundation for a project entitled "Elucidating the role of ferroptosis in renal repair." Total funding will be $35,882.

Jeffrey Crawford of Oncology has received a sub-award through the Alliance NCTN Foundation for a project entitled "Alliance NCTN/NCORP DoD." Total funding will be $1.

Paul Grimsrud of Endocrinology has received a sub-award  through the Wake Forest University for a project entitled "NCDRC P&F April 2021." Total funding will be $25,000.

Adrian Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "PCORnet CC - SCOPE 2: Common Data Model Maintenance, Expansion and Linkage." Total funding will be $4,439,407.

Adrian Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "PCORnet CC - SCOPE 1: Program Management, Collaboration and Coordination." Total funding will be $3,589,386.

Adrian Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "PCORnet CC - SCOPE 4: Strategic Communications to Support the PCORnet Research Community." Total funding will be $1,356,243.

Shiaowen Hsu of Oncology has received an award from the National Institutes of Health for a project entitled "(R21) Microfluidic Droplet Organoids to Decipher the Tumor Heterogeneity in CRC of African Ancestry." Total funding will be $413,972.

Larry Jackson of Cardiology has received an award from the National Institutes of Health for a project entitled "Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation (K01)." Total funding will be $773,569.

William Kraus of Cardiology has received an award from the National Institutes of Health for a project entitled "Exercise-induced Legacy Health Benefits on Cardiometabolic Risk Factors in Aging Adults with Prediabetes." Total funding will be $442,750.

Jay B. Lusk (Mentor: Robert Mentz) of Cardiology has received an award from the American Heart Association for a project entitled "Evaluating Population-Level Disparities in Cardiovascular Disease Progression: A Structural Equation Modeling Approach." Total funding will be $32,036.

Richard Riedel of Oncology has received an award from the Sarcoma Alliance for Research Through Collaboration for a project entitled "Phase 3 Randomized Double-Blind Study of Abemaciclib versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma." Total funding will be $199,110.

Jatin Roper of Gastroenterology has received a sub-award through the University of Utah for a project entitled "Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link." Total funding will be $34,212.

John Strouse of Hematology has received an award from the American Society of Hematology for a project entitled "COVID-19 Vaccine Response in People Living with Sickle Cell Disease." Total funding will be $25,500.

Chris Woods of Infectious Diseases has received a sub-award through the Henry M. Jackson Foundation for a project entitled "Prophylaxis and Treatment of COVID19 - Adaptive Platform Trial (PROTECT-APT)." Total funding will be $1,668,881.

Christina Wyatt of Nephrology has received an award from the National Institutes of Health for a project entitled "The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination." Total funding will be $639,141.

 

Industry Sponsored Clinical Trials

Carey Anders of Oncology has received a sub-award through Hoosier Cancer Research Network, Inc for a project entitled "Phase I/II Study of Stereotactic Radiosurgery with Concurrent Administration of DNA Damage Response (DDR) Inhibitor (Olaparib) Followed by Adjuvant Combination of Durvalumab (MEDI4736) and Physicians." Total funding will be $75,320.

Cristiana Costa Chase of Cell Therapy has received an award from Prothena Biosciences Limited for a project entitled "Prothena:A Phase 3, Randomized, Multicenter, Double-Blind,Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosi." Total funding will be $252,619.

Harry Erba of Cell Therapy has received an award from Kronos Bio, Inc for a project entitled "Kronos | KB-ENTO-3001." Total funding will be $371,449.

Jeremy Force of Oncology has received an award from G1 Therapeutics Inc. for a project entitled "A Phase 3, Randomized, Double-Blind Study of Trilaciclib or Placebo in Patients Receiving First- or Second-Line Gemcitabine and Carboplatin Chemotherapy for Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (PRESERVE 2)." Total funding will be $371,448.

Jeremy Force of Oncology has received an award from Xilis, Inc. for a project entitled "A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer." Total funding will be $268,205.

Vance Fowler of Infectious Diseases has received a sub-award through Deep Blue Medical Advances Inc for a project entitled "A Photochemically 3D Printed High-Resolution Biodegradable Suture Retention Clip." Total funding will be $25,056.

Ahmed Galal of Cell Therapy has received an award from Miltenyi Biomedicine for a project entitled "A multi-center single arm phase II study to evaluate the safety and efficacy of genetically engineered autologous cells expressing anti-CD20 and anti-CD19 specific chimeric antigen receptor in subjects with relapsed and/or refractory diffuse lg Bcell." Total funding will be $558,343.

Daniel George of Oncology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "PSMAfore: Lu-PSMA for men with castrate-resistant prostate cancer." Total funding will be $392,028.

Brent Hanks of Oncology has received an award from Merck Sharp & Dohme for a project entitled "Integrated analysis of a NLRP3-dependent adaptive resistance mechanism to pembrolizumab immunotherapy in advanced gastroesophageal cancer." Total funding will be $452,922.

Michael Harrison of Oncology has received an award from Propella Therapeutics Inc for a project entitled "Propella: Intramuscular abiraterone decanoate for metastatic prostate cancer PRL-02." Total funding will be $296,835.

David Leiman of Gastroenterology has received an award from Revolo Biotherapeutics for a project entitled "A PHASE 2A, DOUBLE-BLIND, PLACEBOCONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF IRL201104 IN ADULT PARTICIPANTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS (EOE)." Total funding will be $116,730.

Lake Morrison of Pulmonary has received an award from Genentech, Inc. for a project entitled "WA42293 PRM-151-303: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS." Total funding will be $548,758.

Lake Morrison of Pulmonary has received an award from Bristol-Myers Squibb Company for a project entitled "IM027040 Phase 2 Study of the efficacy and Safety of BMS-986278 in Pulmonary Fibrosis." Total funding will be $15,017.

Cynthia Moylan of Gastroenterology has received an award from Exact Sciences Corporation for a project entitled "Exact Sciences ALTUS." Total funding will be $188,699.

Andrew Muir of Gastroenterology has received an award from GlaxoSmithKline for a project entitled "A two-part, randomized, placebo controlled, double blind, multicenter, Phase 3 study to evaluate the efficacy and safety of linerixibat for the treatment of cholestatic pruritus in participants with primary biliary cholangitis (PBC).." Total funding will be $99,034.

Nwora Okeke of Infectious Diseases has received a sub-award through PPD Investigator Services, LLC for a project entitled "Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401)) - Synairgen." Total funding will be $2.

Thomas Ortel of Hematology has received an award from Diagnostica Stago for a project entitled "Stago STA� - NeoPTimal 5 and 10 mL Single Site Precision Study." Total funding will be $88,969.

Thomas Ortel of Hematology has received an award from Diagnostica Stago for a project entitled "Stago NeoPTimal 5 mL and 10 mL Multi-Site Precision Study." Total funding will be $25,213.

Thomas Ortel of Hematology has received an award from Precision BioLogic, Inc for a project entitled "PBI - Determination of Reproducibility and Accuracy of CRYOcheck Factor VIII Deficient Plasma with VWF." Total funding will be $19,879.

Neha Pagidipati of Cardiology has received an award from NOVARTIS DE COLOMBIA S.A. for a project entitled "ATHERO Alliance Learning Lab." Total funding will be $64,755.

John Perfect of Infectious Diseases has received an award from Sfunga Therapeutics for a project entitled "AM-2-19 Efficacy Testing in a Mouse Model of Cryptococcosis." Total funding will be $89,320.

Jonathan Piccini of Cardiology has received an award from American Heart Association for a project entitled "AHA GWTG SOW 29." Total funding will be $1,065,245.

Jennifer Rowell of Endocrinology has received an award from Fractyl Laboratories, Inc. for a project entitled "A Prospective, Randomized, Double-Blind, Sham- Controlled, Multi-Center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita� System in Subjects with Type 2 Diabetes on Insulin therapy." Total funding will be $533,972.

April Salama of Oncology has received an award from IDEAYA Biosciences for a project entitled "IDE196 in Metastatic Uveal or Non-Uveal Melanoma with GNAQ/11 Mutations or PRKC Fusions (IDEAYA)." Total funding will be $443,465.

April Salama of Oncology has received an award from Bristoll Myers Squibb for a project entitled "A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy with Relatlimab and Nivolumab Fixed-dose Combination versus Nivolumab Monotherapy after Complete Resection of Stage III-IV Melanoma." Total funding will be $200,887.

Thomas Stinchcombe of Oncology has received an award from Rain Therapeutics, Inc. for a project entitled "A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors." Total funding will be $161,128.